Dear Members of the Waldenstrom’s Macroglobulinemia Community: I wanted to share with you the sad news that our colleague and friend, Dr. Enrica Morra recently passed away. Dr. Morra was the Co-Chair of 6th International Workshop on Waldenstrom’s Macroglobulinemia (IWWM) which was held in Venice, Italy (2010), and a recipient of the Jan Gosta Waldenstrom Award for Lifetime Contributions to Waldenstrom’s Macroglobulinemia at the 8th IWWM in London, UK (2014).

Dr. Morra obtained her medical degree at the University of Pavia and in the same Institution she received post-graduate certificates in both Hematology and Oncology. Since 1973, she worked as a physician in the Hematology Department of the University of Pavia and in 1994 became Head of the Hematology Department and Bone Marrow Transplant Unit at Niguarda Hospital, Milano. She also chaired the Oncology-Hematology Department in the same Institution from 2000.

Her career was marked by close collaboration with scientists but her major focus was on giving effective care to patients suffering from hematological malignancies. Dr. Morra’s main research interests were on the biological and therapeutical aspects of acute leukemias and lymphomas. She also was the principal investigator of Phase II and III clinical trials in acute leukemias and lymphomas. She was a member of the scientific board of the Italian Society of Hematology and Experimental Hematology, and was also a member of the European and American Societies of Hematology.

Dr. Morra taught and supervised at the Postgraduate School of Hematology at the University of Pavia and Milano, and she first established and coordinated the Hematology Network of the Lombardy Region, Italy. In her later years, the major focus of her research was on monoclonal gammopathies (MGUS) and Waldenström Macroglobulinemia (WM). She led a vibrant clinic devoted to the care and study of patients with MGUS and WM at Niguarda Hospital in Milan that attracted patients throughout Italy. In as well, she organized the first patient support groups for WM in Italy. Her research efforts provided fundamental contributions to our understanding of clinical characteristics and factors predicting evolution of IgM monoclonal gammopathies.

She also mentored a new generation of WM faculty, including Drs. Alessandra Tedeschi and Alessandra Trojani who continue her pioneering work in the discovery and care of patients with WM.

We will miss her kind and gentle nature, her mentorship, her advocacy for patients, and the tremendous wisdom and experience she brought to our field. May she rest in peace.

Steve Treon